rewirebio.iobenchmarks
Evidence claim

Relevance of OncoVI three-class assessment: MTB selected expert reassessment to "Assess somatic small-variant oncogenicity"

Use case
Assess somatic small-variant oncogenicity
Assessed by
OncoVI three-class assessment: MTB selected expert reassessment
Relevance
Proxy evidence
Endpoint
Oncogenicity category agreement, sensitivity and reported subgroup performance

Assesses variant classification within the named reference; reference independence and transfer are bounded.

2 reviewed evaluations

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

15 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
1 values
  • source id
    uc-clinical-20260930-source-oncovi
    locator
    Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
2 values
  • A posteriori disagreement-enriched sample; same three experts and same reference resources; blinded to implementation, not independent resource adjudication.
  • Historical MTB 34% agreement with expert review compares functional-impact and oncogenicity labels; OncoVI 22% is against the old MTB labels, while 80% is against expert reassessment. Distinct metrics and references must not be pooled.
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
Oncogenicity category agreement, sensitivity and reported subgroup performance
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Claimed field
links:assessed_by:uc-clinical-20260930-oncovi-expert-protocol
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.field

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Limitations
3 values
  • Not a treatment-selection benchmark.
  • No human domain review of this intake; reference overlap and prospective workload remain unresolved.
  • Abstract/body accuracy discrepancies retained.
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.limitations

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Pinned records
10 values
  • record id
    uc-clinical-20260930-oncovi-expert-evaluation
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    44691a2f0ce6b074049dfa3d9a9d4b55ddf36f32645308624609167ede976b16
  • record id
    uc-clinical-20260930-oncovi-expert-expert-concordance
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    84f714009c637f1e22038b2baa6a5c8e90f520536b51658b0d5c0ec6b2b914ae
  • record id
    uc-clinical-20260930-oncovi-expert-prior-mtb-concordance
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    f3cdde2b0ade891bda340026be2c9d88f5415ba4c3ceb981cd873b5782079ef2
  • record id
    uc-clinical-20260930-oncovi-expert-protocol
    fields
    • status
    • name
    • description
    • facets
    • source_ids
    • links
    • attributes
    sha256
    d20ac49b35e34096d0649d5a3ea7df5815e5f769f0d152e7a408346a32279508
  • record id
    uc-clinical-20260930-oncovi-expert-score-correlation
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    738e1a783b715aa04299d24f6483a2db63b4285ce7eb43142aafde65e3cb8d60
  • record id
    uc-clinical-20260930-oncovi-prior-mtb-expert-agreement
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    5ba63305e7453c599d9c4be11f1fb138e8d560c4c75519e9b2c3691737847560
  • record id
    uc-clinical-20260930-oncovi-prior-mtb-expert-concordant-count
    fields
    • status
    • attributes.metric
    • attributes.metric_qualifier
    • attributes.printed_value
    • attributes.numeric_value
    sha256
    815e31a0bf43049faafeb05b6f6b2126b0e426f8ea8bd06ad1ef38aa9f4552a5
  • record id
    uc-clinical-20260930-oncovi-prior-mtb-expert-evaluation
    fields
    • status
    • links
    • attributes.origin
    • attributes.comparison
    sha256
    e8cc277ba3108eb2ba80119f719a03c800de43e253639ee5909162d1f0dff791
  • record id
    uc-clinical-20260930-source-oncovi
    fields
    • status
    • attributes.artifact_sha256
    sha256
    dad6938e856ad8716c429176c36416ccfc5fb88e76d0e9084c804096a1673d0f
  • record id
    use-case-somatic-small-variant-oncogenicity
    fields
    • status
    • name
    • description
    • facets
    • attributes.question
    • attributes.decision
    • attributes.inputs
    • attributes.output
    • attributes.exclusions
    • attributes.setting
    • attributes.clinical_scope
    • attributes.intended_users
    sha256
    8ccdc2d3923da8c5aa497bf2a0bd40ccafb89fa8b2f04819228dc52657155359
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pins

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Rationale
Assesses variant classification within the named reference; reference independence and transfer are bounded.
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.rationale

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Reason
Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations.
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.reason

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Relevance
proxy
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.relevance

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Revision
1
Context-only references
Oncogenicity Variant Interpreter (OncoVI) Supports Harmonized Somatic Variant Interpretation in Precision Oncology

Original source ↗

uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6

Version: 2026 final full text in Europe PMC XML
Retrieved: 2026-09-30T21:23:41Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.revision

Source artifact SHA-256: 1ced323acfac29704bccfd990cc57692770c324ae598983c6973d271aaaf48b2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-20260930-344-401bec55db2f

field
links:assessed_by:uc-clinical-20260930-oncovi-expert-protocol
value
uc-clinical-20260930-oncovi-expert-protocol
relevance
proxy
endpoint
Oncogenicity category agreement, sensitivity and reported subgroup performance
rationale
Assesses variant classification within the named reference; reference independence and transfer are bounded.
constraints
A posteriori disagreement-enriched sample; same three experts and same reference resources; blinded to implementation, not independent resource adjudication.; Historical MTB 34% agreement with expert review compares functional-impact and oncogenicity labels; OncoVI 22% is against the old MTB labels, while 80% is against expert reassessment. Distinct metrics and references must not be pooled.
limitations
Not a treatment-selection benchmark.; No human domain review of this intake; reference overlap and prospective workload remain unresolved.; Abstract/body accuracy discrepancies retained.
revision
1
reason
Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations.
citation locators
source id: uc-clinical-20260930-source-oncovi; locator: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6
source locator
uc-clinical-20260930-source-oncovi: Results; Figures 2–4; ClinVar assessment; subgroup values referenced to Supplemental Table S6
review
method: automated-source-review; reviewer: codex; reviewer note: Codex source curation, independent worker cross-review and root integration review; reviewed at: 2026-09-30T21:54:30.217Z; note: Source-backed literature curation with independent automated transcription and scope checks. No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
reviewed evaluations
uc-clinical-20260930-oncovi-expert-evaluation; uc-clinical-20260930-oncovi-prior-mtb-expert-evaluation
pins
record id: uc-clinical-20260930-oncovi-expert-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: 44691a2f0ce6b074049dfa3d9a9d4b55ddf36f32645308624609167ede976b16; record id: uc-clinical-20260930-oncovi-expert-expert-concordance; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 84f714009c637f1e22038b2baa6a5c8e90f520536b51658b0d5c0ec6b2b914ae; record id: uc-clinical-20260930-oncovi-expert-prior-mtb-concordance; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: f3cdde2b0ade891bda340026be2c9d88f5415ba4c3ceb981cd873b5782079ef2; record id: uc-clinical-20260930-oncovi-expert-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: d20ac49b35e34096d0649d5a3ea7df5815e5f769f0d152e7a408346a32279508; record id: uc-clinical-20260930-oncovi-expert-score-correlation; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 738e1a783b715aa04299d24f6483a2db63b4285ce7eb43142aafde65e3cb8d60; record id: uc-clinical-20260930-oncovi-prior-mtb-expert-agreement; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 5ba63305e7453c599d9c4be11f1fb138e8d560c4c75519e9b2c3691737847560; record id: uc-clinical-20260930-oncovi-prior-mtb-expert-concordant-count; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 815e31a0bf43049faafeb05b6f6b2126b0e426f8ea8bd06ad1ef38aa9f4552a5; record id: uc-clinical-20260930-oncovi-prior-mtb-expert-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: e8cc277ba3108eb2ba80119f719a03c800de43e253639ee5909162d1f0dff791; record id: uc-clinical-20260930-source-oncovi; fields: status; attributes.artifact_sha256; sha256: dad6938e856ad8716c429176c36416ccfc5fb88e76d0e9084c804096a1673d0f; record id: use-case-somatic-small-variant-oncogenicity; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 8ccdc2d3923da8c5aa497bf2a0bd40ccafb89fa8b2f04819228dc52657155359
Related records

Suggest a correction